Myelination: Do astrocytes play a role?

Neuroscientist

Volumn 19, Issue 5, 2013, Pages 442-450

  Barnett, Susan C ^a   Linington, Christopher ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

astrocytes; CNS; myelination; phenotypes

Indexed keywords

MYELIN;

ARTICLE; ASTROCYTE; CELL DAMAGE; CELL FUNCTION; CELL TYPE; CENTRAL NERVOUS SYSTEM; MULTIPLE SCLEROSIS; MYELINATION; NEUROLOGIC DISEASE; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; REMYELINIZATION; SCAR;

ASTROCYTES; CNS; MYELINATION; PHENOTYPES;

ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM; HUMANS; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE REGENERATION; SYNAPTIC TRANSMISSION;

EID: 84883727292     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858412465655     Document Type: Article

References (90)

1. Albrecht PJ, Herx LM, Yong VW, Levison SW. Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem. 2004 ; 89 (5). 1092-110
2. Althaus HH, Montz H, Neuhoff V, Schwartz P. Isolation and cultivation of mature oligodendroglial cells. Naturwissenschaften. 1984 ; 71 (6). 309-15
3. Ballotti R, Nielsen FC, Pringle N, Kowalski A, Richardson WD, Van Obberghen E. Insulin-like growth factor I in cultured rat astrocytes: expression of the gene, and receptor tyrosine kinase. EMBO J. 1987 ; 6 (12). 3633-9
4. Back SA, Tuohy TM, Chen H, Wallingford N, Craig A, Struve J. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med. 2005 ; 11 (9). 966-72
5. Barres BA. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron. 2008 ; 60 (3). 430-40
6. Barres BA, Lazar MA, Raff MC. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development. 1994 ; 120 (5). 1097-108
7. Bhat S, Pfeiffer SE. Stimulation of oligodendrocytes by extracts from astrocyte-enriched cultures. J Neurosci Res. 1986 ; 15 (1). 19-27
8. Blakemore WF, Crang AJ. The relationship between type-1 astrocytes, Schwann cells and oligodendrocytes following transplantation of glial cell cultures into demyelinating lesions in the adult rat spinal cord. J Neurocytol. 1989 ; 18 (4). 519-28
9. Bögler O, Wren D, Barnett SC, Land H, Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci U S A. 1990 ; 87 (16). 6368-72
10. Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D, Goldman JE, Messing A. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet. 2001 ; 27 (1). 117-20
11. Buttery PC, ffrench-Constant C. Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes. Mol Cell Neurosci. 1999 ; 14 (3). 199-212
12. Cambron M, D'Haeseleer M, Laureys G, Clinckers R, Debruyne J, De Keyser J. White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis. J Cereb Blood Flow Metab. 2012 ; 32 (3). 413-24
13. Chan JR, Watkins TA, Cosgaya JM, Zhang C, Chen L, Reichardt LF. NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron. 2004 ; 43 (2). 183-91
14. Clarke SR, Shetty AK, Bradley JL, Turner DA. Reactive astrocytes express the embryonic intermediate neurofilament nestin. Neuroreport. 1994 ; 5 (15). 1885-8
15. Deng YY, Lu J, Ling EA, Kaur C. Microglia-derived macrophage colony stimulating factor promotes generation of proinflammatory cytokines by astrocytes in the periventricular white matter in the hypoxic neonatal brain. Brain Pathol. 2010 ; 20 (5). 909-25
16. Dietrich J, Lacagnina M, Gass D, Richfield E, Meyer-Proschel M, Noble M. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy. Nat Med. 2005 ; 11 (3). 277-83
17. Eddleston M, Mucke L. Molecular profile of reactive astrocytes:- implications for their role ion neurologic disease. Neuroscience. 1993 ; 54 (1). 115-36
18. Edgar JM, Nave KA. The role of CNS glia in preserving axon function. Curr Opin Neurobiol. 2009 ; 19 (5). 498-504
19. Elliott C, Lindner M, Arthur A, Brennan K, Jarious S, Hussey J. Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis. Brain. 2012 ; 135 (Pt 6). 1819-33
20. Eng LF, Ghirnikar RS. GFAP and astroglyosis. Brain Pathol. 1994 ; 4 (3). 229-37
21. Emery B. Transcriptional and post-transcriptional control of CNS myelination. Curr Opin Neurobiol. 2010 ; 20 (5). 601-7
22. Faissner A, Pyka M, Geissler M, Sobik T, Frischknecht R, Gundelfinger ED. Contributions of astrocytes to synapse formation and maturation: potential functions of the perisynaptic extracellular matrix. Brain Res Rev. 2010 ; 63 (1-2). 26-38
23. Fancy SP, Chan JR, Baranzini SE, Franklin RJ, Rowitch DH. Myelin regeneration: a recapitulation of development?. Annu Rev Neurosci. 2011 ; 34: 21-43
24. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci. 2004 ; 24 (9). 2143-55
25. Fernaud-Espinosa I, Nieto-Sampedro M, Bovolenta P. Differential activation of microglia and astrocytes in aniso- and isomorphic gliotic tissue. Glia. 1993 ; 8 (4). 277-91
26. Franklin RJ, Crang AJ, Blakemore WF. Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord. J Neurocytol. 1991 ; 20 (5). 420-30
27. Goldman JE, Vaysse PJ. Tracing glial cell lineages in the mammalian forebrain. Glia. 1991 ; 4 (2). 149-56
28. Hagemann TL, Boelens WC, Wawrousek EF, Messing A. Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease. Hum Mol Genet. 2009 ; 18 (7). 1190-9
29. Haj-Yasein NN, Vindedal GF, Eilert-Olsen M, Gundersen GA, Skare Ø, Laake P. Glial-conditional deletion of aquaporin-4 (Aqp4) reduces blood-brain water uptake and confers barrier function on perivascular astrocyte endfeet. Proc Natl Acad Sci U S A. 2011 ; 108 (43). 17815-20
30. Hamby ME, Sofroniew MV. Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics. 2010 ; 7 (4). 494-506
31. Hinson SR, McKeon A, Lennon VA. Neurological autoimmunity targeting aquaporin-4. Neuroscience. 2010 ; 168 (4). 1009-18
32. Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med. 2008 ; 205 (11). 2473-81
33. Hudgins SN, Levison SW. Ciliary neurotrophic factor stimulates astroglial hypertrophy in vivo and in vitro. Exp Neurol. 1998 ; 150 (2). 171-82
34. Holley JE, Gveric D, Whatmore JL, Gutowski NJ. Tenascin C induces a quiescent phenotype in cultured adult human astrocytes. Glia. 2005 ; 52 (1). 53-8
35. Howe CL. Coated glass and vicryl microfibers as artificial axons. Cells Tissues Organs. 2006 ; 183 (4). 180-94
36. Iannotti C, Li H, Yan P, Lu X, Wirthlin L, Xu XM. Glial cell line-derived neurotrophic factor-enriched bridging transplants promote propriospinal axonal regeneration and enhance myelination after spinal cord injury. Exp Neurol. 2003 ; 183 (2). 379-93
37. Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol. 2008 ; 4 (4). 202-14
38. Jarjour AA, Zhang H, Bauer N, ffrench-Constant C, Williams A. In vitro modeling of central nervous system myelination and remyelination. Glia. 2012 ; 60 (1). 1-12
39. Kerstetter AE, Padovani-Claudio DA, Bai L, Miller RH. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis. Exp Neurol. 2009 ; 220 (1). 44-56
40. Kotter MR, Stadelmann C, Hartung HP. Enhancing remyelination in disease - can we wrap it up?. Brain. 2011 ; 134 (7). 1882-900
41. Kremer D, Aktas O, Hartung HP, Küry P. The complex world of oligodendroglial differentiation inhibitors. Ann Neurol. 2011 ; 69 (4). 602-18
42. Kumar S, Biancotti JC, Yamaguchi M, de Vellis J. Combination of growth factors enhances remyelination in a cuprizone-induced demyelination mouse model. Neurochem Res. 2007 ; 32 (4-5). 783-97
43. Liberto CM, Albrecht PJ, Herx LM, Yong VW, Levison SW. Proregenerative properties of cytokine-activated astrocytes. J Neurochem. 2004 ; 89 (5). 1092-100
44. Maysami S, Nguyen D, Zobel F, Pitz C, Heine S, Höpfner M. Modulation of rat oligodendrocyte precursor cells by the chemokine CXCL12. Neuroreport. 2006 ; 17 (11). 1187-90
45. Miljković D, Timotijević G, Mostarica Stojković M. Astrocytes in the tempest of multiple sclerosis. FEBS Lett. 2011 ; 585 (23). 3781-8
46. Milner R, Frost E, Nishimura S, Delcommenne M, Streuli C, Pytela R. Expression of alpha vbeta3 and alpha vbeta8 integrins during oligodendrocyte precursor differentiation in the presence and absence of axons. Glia. 1997 ; 21 (4). 350-60
47. Miron VE, Kuhlmann T, Antel P. Cells of the oligodendroglial lineage, myelination and remyelination. Biochim Biophys Acta. 2011 ; 1812 (2). 184-93
48. Mohan H, Krumbholz M, Sharma R, Eisele S, Junker A, Sixt M. Extracellular matrix in multiple sclerosis lesions: fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells. Brain Pathol. 2010 ; 20 (5). 966-75
49. Moore CS, Abdullah SL, Brown A, Arulpragasam A, Crocker SJ. How factors secreted from astrocytes impact myelin repair. J Neurosci Res. 2011a ; 89 (1). 13-21
50. Moore CS, Crocker SJ. An alternate perspective on the roles of TIMPs and MMPs in pathology. Am J Pathol. 2012 ; 180 (1). 12-6
51. Moore CS, Milner R, Nishiyama A, Frausto RF, Serwanski DR, Pagarigan RR. Astrocytic tissue inhibitor of metalloproteinase-a (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination. J Neurosci. 2011b ; 31 (16). 6247-54
52. Morcos Y, Lee SM, Levin MC. A role for hypertrophic astrocytes and astrocytes precursors in a case of rapidly progressive multiple sclerosis. Mult Scler. 2003 ; 9 (4). 322-41
53. Müller E Die multiple Skleroze des Gehirns und Rückenmarks: ihre Pathologie und Behandlung. Jena, Germany: G. Fischer ; 1904: 300-44.
54. Nair A, Frederick TJ, Miller SD. Astrocytes in multiple sclerosis: a product of their environment. Cell Mol Life Sci. 2008 ; 65 (17). 2702-20
55. Nash B, Thomson C, Linington C, Athur A, McCLure JD, McBride M. Modulating astrocyte phenotype affects myelination and is negatively mediated by cxcl10. J Neurosci. 2011 ; 31 (37). 13028-38
56. Noble M, Murray K, Stroobant P, Waterfield M, Riddle F. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type 2 astrocyte progenitor cell. Nature. 1988 ; 333 (6173). 560-62
57. Noble M, Murray K. Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell. EMBO J. 1984 ; 3 (10). 2243-47
58. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia. 2005 ; 50 (4). 427-34
59. Raff MC, Abney ER, Fok-Sean J. Reconstitution of a developmental clock in vitro: a critical role for astrocytes in the timing of oligodendrocyte differentiation. Cell. 1985 ; 42 (1). 61-9
60. Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD. Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature. 1988 ; 333 (6173). 562-5
61. Raff MC, Miller RH, Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature. 1983 ; 303 (5916). 390-6
62. Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M.. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell. 1988 ; 53 (2). 309-19
63. Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 1997 ; 20 (12). 570-7
64. Rosenberg SS, Kelland EE, Tokar E, De la, Torre AR, Chan JR. The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation. Proc Natl Acad Sci U S A. 2008 ; 105 (38). 14662-7
65. Satoh J, Tabunoki H, Yamamura T, Arima K, Konno H. TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions. Neuropathol Appl Neurobiol. 2007 ; 33 (1). 99-107
66. See JM, Grinspan JB. Sending mixed signals: bone morphogenetic protein in myelination and demyelination. J Neuropathol Exp Neurol. 2009 ; 68 (6). 595-604
67. Sendtner M, Carroll P, Holtmann B, Hughes RA, Thoenen H. Ciliary neurotrophic factor. J Neurobiol. 1994 ; 25 (11). 1436-53
68. Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci. 2004 ; 5 (2). 146-56
69. Sloane JA, Batt C, Ma Y, Harris ZM, Trapp B, Vartanian T. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci U S A. 2010 ; 107 (25). 11555-60
70. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009 ; 32 (12). 638-47
71. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neurpathol. 2010 ; 119 (1). 7-35
72. Sorensen A, Moffat K, Thomson C, Barnett SC. Astrocytes, but not olfactory ensheathing cells or Schwann cells, promote myelination of CNS axons in vitro. Glia. 2008 ; 56 (7). 750-63
73. Stankoff B, Aigrot MS, Noël F, Wattilliaux A, Zalc B, Lubetzki C. Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J Neurosci. 2002 ; 22 (21). 9221-7
74. Stevens B, Porta S, Haak LL, Gallo V, Fields RD. Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials. Neuron. 2002 ; 36 (5). 855-68
75. Stritt C, Stern S, Harting K, Manke T, Sinske D, Schwarz H. Paracrine control of oligodendrocyte differentiation by SRF-directed neuronal gene expression. Nat Neurosci. 2009 ; 12 (4). 418-27
76. Szuchet S, Polak PE, Yim SH. Mature oligodendrocytes cultured in the absence of neurons recapitulate the ontogenic development of myelin membranes. Dev Neurosci. 1986 ; 8 (4). 208-21
77. Talbott JF, Loy DN, Liu Y, Qiu MS, Bunge MB, Rao MS. Endogenous Nkx2.2+/Olig2+ oligodendrocytes precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Exp Neurol. 2005 ; 192 (1). 11-24
78. Taveggia C, Thaker P, Petrylak A, Caporaso GL, Toews A, Falls DL. Type III neuregulin-1 promotes oligodendrocyte myelination. Glia. 2008 ; 56 (3). 284-93
79. Temple S, Raff MC. Differentiation of a bipotential glial progenitor cell in single cell microculture. Nature. 1985 ; 313 (5999). 223-5
80. Thomson CE, McCulloch M, Sorenson A, Barnett SC, Seed BV, Griffiths IR. Myelinated, synapsing cultures of murine spinal cord - validation as an in vitro model of the central nervous system. Eur J Neurosci. 2008 ; 28 (8). 1518-35
81. Tian R, Wu X, Hagemann TL, Sosunov AA, Messing A, McKhann GM. Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes. J Neuropathol Exp Neurol. 2010 ; 69 (4). 335-45
82. Toft-Hansen H, Nuttall RK, Edwards DR, Owens T. Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J Immunol. 2004 ; 173 (8). 5209-18
83. Ullian EM, Sapperstein SK, Christopherson KS, Barres BA. Control of synapse number by glia. Science. 2001 ; 291 (5504). 657-61
84. Voskuhl RR, Peterson RS, Song B, Ao Y, Morales LB, Tiwari-Woodruff S. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci. 2009 ; 29 (37). 11511-22
85. Wang Y, Cheng X, He Q, Zheng Y, Kim DH, Whittemore SR. Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins. J Neurosci. 2011 ; 31 (16). 6053-8
86. Watkins TA, Emery B, Mulinyawe S, Barres BA. Distinct stages of myelination regulated by γ-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron. 2008 ; 60 (4). 555-69
87. Williams A, Piaton G, Lubetzki C. Astrocytes - friends or foes in multiple sclerosis. Glia. 2007 ; 55 (13). 1300-12
88. Xiao J, Wong AW, Willingham MM, van den Buuse M, Kilpatrick TJ, Murray SS. Brain-derived neurotrophic factor promotes central nervous system myelination via a direct effect upon oligodendrocytes. Neurosignals. 2010 ; 18 (3). 186-202
89. Yin LL, Lin LL, Zhang L, Li L. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses. Neuropharmacology. 2012 ; 63 (5). 851-62
90. Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard R. Genomic analysis of reactive astrocytes. J Neurosci. 2012 ; 32 (18). 6391-410